KDR and neoplasm: Using transgenic fluorescent zebrafish embryos Tg (Fli-1: EGFP) and human umbilical vein endothelial cells (HUVECs), we demonstrated that SB218078 significantly reduces tumor angiogenesis by inhibiting VEGF-induced phosphorylation of VEGFR2 and its downstream signaling pathways.